Blog

AGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More

AGC Inc. (TYO:5201) is looking to invest more than 200 billion yen ($1.7 billion) into CDMO operations by 2025. Plans……

Please subscribe to read the full story.

Author

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *